Focus is now on the laboratory analyses of samples collected...

Focus is now on the laboratory analyses of samples collected during the trial. Preliminary results are
expected to be available in September 2023. (August 16th)

Also:

As previously advised, all three trials were successfully completed, and efforts in recent months have been
focused on post-trial activities that are essential parts of the clinical assessment of new drugs. (Dec 14).

This one indicates that "post-trial activities" are underway - that would mean initial results are in and that further analysis on those results are being undertaken.